Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,137 Jan 1 – Oct 9, 2026
- Disclosed funding
- $200.7B 1769 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| D DatabentoCompany profile Provides real-time and historical market data across futures, options, and equities through a unified API Provides real-time and historical market data across futures, options, and equities through a unified API | $97M | Series B | Fintech | United States | Investors | |
| PI Prime IntellectCompany profile Provides computing power and software tools to help companies build AI agents Provides computing power and software tools to help companies build AI agents | $130M | Series A | AI | United States | Investors | |
| KA Develops microalgal ingredients using dark fermentation. | Undisclosed | Series B | Biotech | United States | Investors | |
| E EdVisorlyCompany profile Provides automation and workflow solutions for college admissions and enrollment operations Provides automation and workflow solutions for college admissions and enrollment operations | $13.3M | Series A | Edtech | United States | Investors | |
| S SambaNovaCompany profile Provides next-generation AI infrastructure for enterprises, neo-clouds, and sovereign AI initiatives Provides next-generation AI infrastructure for enterprises, neo-clouds, and sovereign AI initiatives | $1B | Series FSeries C+ | AI | United States | Investors | |
 Allotera TherapeuticsCompany profile Clinical-stage developer of off-the-shelf CAR-T cell therapies, including Sofi-cel for aggressive T-cell cancers. Clinical-stage developer of off-the-shelf CAR-T cell therapies, including Sofi-cel for aggressive T-cell cancers. | $35M | Series C extension and venture debtSeries C+ | Biotech | United States | Investors | |
| LC Leo Cancer CareCompany profile Develops cancer-care systems for treating patients in an upright position. Develops cancer-care systems for treating patients in an upright position. | $65M | Series DSeries C+ | Healthtech | United States | Investors | |
| PH Pearl HealthCompany profile Provides an AI platform for healthcare providers to manage risk and improve care for Medicare patients Provides an AI platform for healthcare providers to manage risk and improve care for Medicare patients | $110M | Equity+DebtUndisclosed | Healthtech | United States | Investors | |
| H AI-powered virtual concierge for restaurants | $12M | Series A | Foodtech | United States | Investors | |
| H HandspringCompany profile Provides evidence-based virtual mental health care to youth, young adults, and their families Provides evidence-based virtual mental health care to youth, young adults, and their families | $19M | Series B | Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Nous Research, Santé, Vitalize
126rounds3led - 2Andreessen Horowitz (a16z)
TypeSafe AI, Arena, Vesta
94rounds18led - 3General Catalyst
Minerva Humanoids, Melius
65rounds6led - 4Alumni Ventures
Savvy Wealth, Ocular AI, Mona
56rounds0led - 5Khosla Ventures
Arena, Vinci, Conway Research
54rounds5led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.